New approaches to the treatment of endometriosis

The results of the study that involving 64 women with endometriosis have shown that the use in the treatment of L-arginine (the drug Tivortin) has a direct impact on the underlying factors that play role in the development and progression of endometriosis. It makes the use of non-hormonal drug promising in treatment of endometriosis andhas an important role in the prevention of its recurrence.